International Development Grant
Support to COVID-19 Diagnostics
Project Number: CA-3-P009757001
Status: Terminating
Country/Region: Unknown
Regional Focus:
Maximum Contribution: $20,000,000.00
Start Date: March 30, 2021
End Date: March 31, 2025
Duration: 4.0 years
Project Description
This project supports the Foundation for Innovative New Diagnostics (FIND) in accelerating the roll-out of safe affordable and effective COVID-19 diagnostics in Low- and Lower-Middle Income Countries. It contributes to the global COVID-19 response set out in the Access to COVID-19 Tools Accelerator Diagnostics Partnership. Project activities include: (1) developing rapid and affordable COVID-19 tests for use in lower-income countries; and (2) building and deploying new testing and market shaping strategies to meet the changing needs of the pandemic response.
Expected Results
The expected outcomes of this project include: (1) increased capacity of manufacturers to research and develop rapid diagnostic tests; and (2) enhanced access to simple accurate and affordable COVID-19 tests for Lower-Middle Income Countries.
Progress & Results Achieved
Results achieved as of May 2023 include: (1) procured 193 million tests through the Access to COVID-19 Tools Accelerator Diagnostics Consortium for Lower-Middle Income Countries; and (2) reduced COVID-19 test pricing. This includes reducing the polymerase chain reaction test price from US$20-30 to less than $10 per test and quality-assured rapid diagnostic tests from more than US$5 to less than US$1.
Key Information
Executing Agency:
Foundation for Innovative New Diagn
Reporting Organization:
Global Affairs Canada
Program:
YFMInternaAssistPartnershp&Programing Br
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Project-type interventions
Collaboration: Bilateral
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Department-Initiated